Markers of coagulation and inflammation and adverse events in patients with active cancer and atherosclerosis: common features and differences

Markers of coagulation and inflammation and adverse events in patients with active cancer and atherosclerosis: common features and differences

Introduction. Thrombotic complications (TC) in different vascular systems dictate the fate of high-risk patients. In cardiological practice, patients with advanced atherosclerotic vascular disease (MFA) represent the most vulnerable group. Malignant neoplasm (MN) is one of the most significant risk...

ver descrição completa

Detalhes bibliográficos
Main Authors:	Yu. A. Fedotkina, A. L. Komarov, А. В. Dobrovolsky, E. N. Krivosheeva, О. О. Frolkova, E. V. Titaeva, T. V. Balakhonova, Е. Р. Panchenko
Formato:	Artigo
Idioma:	Russian
Publicado em:	«REMEDIUM GROUP» Ltd. 2023-01-01
Colecção:	Атеротромбоз
Assuntos:	active cancer multifocal atherosclerosis d-dimer gdf-15 vegf-a prognosis determining outcomes
Acesso em linha:	https://www.aterotromboz.ru/jour/article/view/287

Registos relacionados

GDF-15 and the risk of bleeding in patients with stable CAD receiving multicomponent antithrombotic therapy: the results of the prospective REGATA register
Por: Elena N. Krivosheeva, et al.
Publicado em: (2024-07-01)

Growth differentiation factor 15 and the risk of cardiovascular events in patients with atrial fibrillation after elective percutaneous coronary intervention
Por: E. N. Krivosheeva, et al.
Publicado em: (2021-08-01)

Serum Concentration of Growth Differentiation Factor 15 and Atherosclerosis among General Older Japanese Individuals with Normal Weight
Por: Yuji Shimizu, et al.
Publicado em: (2023-05-01)

Assessment of the Anticancer Effects of Simvastatin on Human Osteosarcoma and Colorectal Cancer Cell Lines
Por: Sarah Mazin Naeem, et al.
Publicado em: (2024-12-01)

Relationship between lipid profile parameters, coagulation system and inflammation markers in patients with hypertension and multifocal atherosclerosis
Por: S. S. Vedenskaya, et al.
Publicado em: (2024-12-01)

Growth differentiation factor-15 as a biomarker of atherosclerotic coronary plaque: Value in people living with and without HIV
Por: Léna Royston, et al.
Publicado em: (2022-08-01)

Interrelation of growth/differentiation factor-15 level with laboratory and clinical and functional parameters of patients with coronary artery disease
Por: E. A. Zakharyan
Publicado em: (2023-06-01)

Prognostic significance of atherosclerosis of one or two vascular systems in patients with high and very high cardiovascular risk
Por: V. V. Genkel, et al.
Publicado em: (2021-03-01)

Determinants of growth differentiation factor 15 plasma levels in outpatients with peripheral arterial disease
Por: Emma Skau, et al.
Publicado em: (2024-12-01)

Growth Differentiation Factor 15 and Risk of Bleeding Events: The Atherosclerosis Risk in Communities Study
Por: Lena Mathews, et al.
Publicado em: (2023-03-01)

Diagnosis of multifocal atherosclerosis in low-to moderate-risk patients and their restratification
Por: O. V. Fatenkov, et al.
Publicado em: (2020-11-01)

Features of atherosclerosis in carotid and coronary arteries
Por: E. V. Konstantinova, et al.
Publicado em: (2021-10-01)

Albuminuria as a marker of atherosclerosis burden and a possible predictor of adverse events in patients with polyvascular disease
Por: Olga O. Shakhmatova, et al.
Publicado em: (2023-11-01)

Growth differentiation factor-15/adiponectin ratio as a potential biomarker for metabolic syndrome in Han Chinese
Por: Shuai Zheng, et al.
Publicado em: (2023-04-01)

Diagnostic and prognostic significance of D-dimer in internal medicine
Por: Yu A Fedotkina, et al.
Publicado em: (2003-12-01)

GDF‐15 is associated with atherosclerosis in adults with transfusion‐dependent beta‐thalassemia
Por: Alaa Efat, et al.
Publicado em: (2022-05-01)

The effect of acute and chronic exercise on circulating GDF-15: a systematic review and meta-analysis
Por: Mousa Khalafi, et al.
Publicado em: (2023-08-01)

The effect of acute and chronic exercise on circulating GDF-15: a systematic review and meta-analysis
Por: Mousa Khalafi, et al.
Publicado em: (2023-08-01)

Clinical and prognostic importance of assessment of interleukin-12 blood concentration in patients with multifocal atherosclerosis after carotid endarterectomy
Por: A. V. Frolov, et al.
Publicado em: (2014-06-01)

Strategy for endovascular treatment of a patient with combined coronary and carotid artery atherosclerosis: a case report
Por: F. B. Shukurov, et al.
Publicado em: (2023-01-01)

Do the patients with peripheral atherosclerosis need to a medical therapy before the revascularization?
Por: O L Barbarash, et al.
Publicado em: (2019-12-01)

Risk factors for and prognostic value of multifocal atherosclerosis in patients with diabetes mellitus
Por: S A Gracheva, et al.
Publicado em: (2014-10-01)

Association between Serum GDF-15 and Cognitive Dysfunction in Hemodialysis Patients
Por: Hae Ri Kim, et al.
Publicado em: (2024-02-01)

Neutralization of GDF15 Prevents Anorexia and Weight Loss in the Monocrotaline-Induced Cardiac Cachexia Rat Model
Por: Bina Albuquerque, et al.
Publicado em: (2022-03-01)

Serum growth differentiation factor-15 and non-esterified fatty acid levels in patients with coronary artery disease and hyperuricemia
Por: Jingru Cheng, et al.
Publicado em: (2023-03-01)

Role of GDF-15 as an inflammatory marker in patients with psoriasis vulgaris
Por: Mustafa Kaan Taşolar, et al.
Publicado em: (2021-12-01)

Sex-specific modulation of circulating growth differentiation factor-15 in patients with type 2 diabetes and/or obesity
Por: Mohamed Asrih, et al.
Publicado em: (2022-07-01)

Atherosclerosis of peripheral arteries in patients with coronary artery disease and type 2 diabetes mellitus
Por: V V Genkel, et al.
Publicado em: (2019-10-01)

RELATIONSHIP OF MULTIFOCAL ATHEROSCLEROSIS AND RENAL DYSFUNCTION WITH IN-HOSPITAL COMPLICATIONS AFTER CORONARY BYPASS OPERATION IN ISCHEMIC HEART DISEASE
Por: K. S. Shafranskaya, et al.
Publicado em: (2015-03-01)

Cardiovascular Comorbidity: Patient with Coronary Artery Disease and Peripheral Artery Atherosclerosis. How to Identify and Manage the Risks of Ischemic Events?
Por: O. L. Barbarash, et al.
Publicado em: (2020-09-01)

Markers of hemostasis activation and endothelial damage in patients with active cancer
Por: A. B. Dobrovolsky, et al.
Publicado em: (2022-06-01)

A patient with сoronary artery disease and multifocal atherosclerosis. How to optimize the prognosis?
Por: O. L. Barbarash, et al.
Publicado em: (2018-09-01)

Concentrations of oocyte secreted GDF9 and BMP15 decrease with MII transition during human IVM
Por: Jesús Cadenas, et al.
Publicado em: (2022-08-01)

The relationship between the level of Lр(а) and the prevalence of atherosclerosis among young patients
Por: Elena A. Klesareva, et al.
Publicado em: (2022-05-01)

Association of cardiac troponin T and growth differentiation factor 15 with replacement and interstitial cardiac fibrosis in community dwelling adults: The multi-ethnic study of atherosclerosis
Por: Christopher R. deFilippi, et al.
Publicado em: (2023-02-01)

Increased Growth Differentiation Factor 15 Levels Are Associated with HIV-Associated Neurocognitive Impairment: A Pilot Study
Por: Ali Boustani, et al.
Publicado em: (2025-01-01)

SHORT-TERM RESULTS OF CARDIOSYNCHRONIZED CONSEQUENTIAL ANTEGRADE PNEUMOCOMPRESSION IN PATIENTS WITH MULTIFOCAL ATHEROSCLEROSIS
Por: O. U. Atkov, et al.
Publicado em: (2015-03-01)

Maternal levels of growth differentiation factor-15 in patients with preeclampsia
Por: Ilkbal Temel Yuksel, et al.
Publicado em: (2018-10-01)

Growth differentiation factor 15: an emerging diagnostic biomarker of liver fibrosis in chronic hepatitis C patients
Por: Heba M. Adel Abou Zaghla, et al.
Publicado em: (2021-01-01)

SURGICAL TREATMENT OF MULTIFOCAL ATHEROSCLEROSIS: CORONARY AND BRACHIOCEPHALIC PATHOLOGY AND PREDICTORS OF EARLY ADVERSE EVENTS DEVELOPMENT
Por: R. S. Tarasov, et al.
Publicado em: (2017-08-01)